Nature Communications (Dec 2020)

In vivo diversification of target genomic sites using processive base deaminase fusions blocked by dCas9

  • Beatriz Álvarez,
  • Mario Mencía,
  • Víctor de Lorenzo,
  • Luis Ángel Fernández

DOI
https://doi.org/10.1038/s41467-020-20230-z
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 14

Abstract

Read online

In vivo mutagenesis systems can often show restricted capabilities and deleterious off-site mutations. Here the authors fuse base deaminases to T7 RNA polymerase to mutate a target sequence and use dCas9 to define the boundaries of the diversified DNA.